Crispr Therapeutics shares owned by Privium Fund Management B.V.
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Privium Fund Management B.V.
from 13F filings
Historical chart of Privium Fund Management B.V. investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Privium Fund Management B.V. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Privium Fund Management B.V.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.4M | 30k | 46.98 |
| 2024-06-30 | $1.5M | 27k | 53.12 |
| 2024-03-31 | $869k | 13k | 68.16 |
| 2023-12-31 | $842k | 13k | 66.06 |
| 2023-09-30 | $327k | 7.2k | 45.39 |
| 2023-06-30 | $342k | 6.0k | 57.02 |
| 2023-03-31 | $271k | 6.0k | 45.23 |
| 2022-03-31 | $235k | 3.8k | 62.67 |
More positions owned by Privium Fund Management B.V.
View all positions for Privium Fund Management B.V.